Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 19:57
Indivior Pharmaceuticals Price : 36.18 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 37.68 | 38.52 | 36.70 | 36.87 | 2.497M |
| Aug 20, 2026 | 38.91 | 39.25 | 37.64 | 37.78 | 1.442M |
| Aug 19, 2026 | 39.90 | 40.00 | 38.72 | 39.04 | 2.477M |
| Aug 18, 2026 | 39.48 | 39.92 | 39.08 | 39.43 | 2.339M |
| Aug 17, 2026 | 38.95 | 39.59 | 38.68 | 39.08 | 2.018M |
| Aug 14, 2026 | 38.00 | 39.14 | 37.82 | 39.01 | 988395.0 |
| Aug 13, 2026 | 39.12 | 39.12 | 38.02 | 38.22 | 2.337M |
| Aug 12, 2026 | 38.50 | 39.15 | 37.86 | 38.73 | 2.572M |
| Aug 11, 2026 | 38.82 | 39.29 | 38.39 | 38.43 | 2.213M |
| Aug 10, 2026 | 38.09 | 39.09 | 37.95 | 38.47 | 2.066M |
| Aug 07, 2026 | 38.83 | 38.91 | 38.08 | 38.82 | 1.687M |
| Aug 06, 2026 | 39.04 | 39.74 | 38.53 | 38.67 | 2.676M |
| Aug 05, 2026 | 36.28 | 39.44 | 36.28 | 38.73 | 4.275M |
| Aug 04, 2026 | 37.94 | 38.04 | 35.76 | 36.50 | 7.155M |
| Aug 03, 2026 | 40.31 | 41.18 | 36.70 | 37.37 | 6.684M |
| Jul 31, 2026 | 39.96 | 40.30 | 38.63 | 40.01 | 1.352M |
| Jul 30, 2026 | 40.18 | 40.60 | 39.66 | 40.22 | 1.581M |
| Jul 29, 2026 | 41.28 | 41.65 | 39.97 | 40.10 | 1.496M |
| Jul 28, 2026 | 40.10 | 41.28 | 39.90 | 40.99 | 1.778M |
| Jul 27, 2026 | 40.62 | 40.99 | 40.01 | 40.03 | 998380.0 |
| Jul 24, 2026 | 40.83 | 40.95 | 40.08 | 40.52 | 837610.0 |
| Jul 23, 2026 | 39.81 | 40.70 | 39.65 | 40.51 | 2.387M |
| Jul 22, 2026 | 39.96 | 40.57 | 39.87 | 40.45 | 968101.0 |
| Jul 21, 2026 | 39.02 | 40.57 | 38.56 | 40.45 | 1.840M |
| Jul 20, 2026 | 40.54 | 41.00 | 39.01 | 39.12 | 2.541M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Supernus Pharmaceuticals, Inc. | 45.11 |
| Liquidia Corp. | 70.28 |
| Corcept Therapeutics, Inc. | 123.20 |
| Amneal Pharmaceuticals, Inc. | 17.78 |
| Prestige Consumer Healthcare, Inc. | 52.01 |
Price Related Metrics
| PE Ratio | 12.85 |
| PS Ratio | 3.443 |
| PEG Ratio | 0.0558 |
| Earnings Yield | 7.78% |
| Market Cap | 4.269B |
| PEGY Ratio | 0.0558 |
| Operating PE Ratio | 8.620 |
| Normalized PE Ratio | 10.14 |